Herceptin become most prescribed biologic with KRW 100 billion
‘Herceptin,’ a breast cancer therapy, has become the only biologic with more than KRW 100 billion prescriptions a year.
CoreZetta(CEO Hong-Ki Lee), a health care big data company, analyzed data about 22 biologics turned in to the Health Insurance Review & Assessment Service, and the analysis sho...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.